Syra Health Corp
NASDAQ:SYRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (1.2), the stock would be worth $0.21 (51% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2.4 | $0.42 |
0%
|
| 3-Year Average | 1.2 | $0.21 |
-51%
|
| 5-Year Average | 1.2 | $0.21 |
-51%
|
| Industry Average | 1.7 | $0.29 |
-31%
|
| Country Average | 2.5 | $0.44 |
+4%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| US |
S
|
Syra Health Corp
NASDAQ:SYRA
|
5.1m USD | 2.4 | -5.6 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
292.6B USD | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 1 319.4 | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
100.8B ZAR | 1 | 10.4 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
67.3B USD | 1 940.1 | 38 034.1 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
53B USD | 0 | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
37.1B CHF | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
31.4B EUR | 7.9 | 175.7 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
34.4B USD | 51.5 | -3 150.7 | |
| ZA |
V
|
Vukile Property Fund Ltd
JSE:VKE
|
29.6B ZAR | 1 | 6.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.5 |
| Median | 2.5 |
| 70th Percentile | 4.8 |
| Max | 147 580.5 |
Other Multiples
Syra Health Corp
Glance View
Syra Health Corp is a US-based company operating in industry. The company is headquartered in Carmel, Indiana. The company went IPO on 2023-09-29. Syra Health Corp. is a healthcare services company. The firm offers comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health. The firm within its health education service line offers services, including medical communications, patient education, and healthcare training. Its population health management services include analytics as a service, epidemiology and health equity analytics solutions. The Company’s digital health solutions include digital transformation, cloud and security, artificial intelligence, patient engagement, and health applications. The firm provides workforce staffing solutions, health education and healthcare research consulting services to mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities and pharmaceutical manufacturers.
